Webinar| Biomanufacturing Strategies for Meeting Commercial Demand
June 30, 2022
We are excited to partner with Terrapinn for a live webinar
Join us Thursday – June 30, 2022, 10:00 AM – 11:00 AM EDT
Nick Hutchinson, Business Steering Group Leader for Mammalian Cell Culture at FUJIFILM Diosynth Biotechnologies will be presenting on Biomanufacturing Strategies for Meeting Commercial Demand
Biopharmaceutical companies must make crucial decisions about their commercial manufacturing strategies despite having uncertain data about demand forecasts. This presentation will describe each strategy and the benefits of each in different scenarios.
- Production in facilities with multiple 20,000-L cell culture bioreactors is very efficient and will deliver low Cost of Goods, especially for high volume products.
- High-throughput single-use ballroom facilities provide a flexible alternative to large-scale stainless steel manufacturing plants and are well suited towards highly targeted therapeutics addressing niche markets.
- Continuous biomanufacturing strategies are now available which provide a high productivity yet flexible option to companies commercializing biologics.